OCT 24, 2019 9:43 PM PDT

Patients can Self-Inject Easily Using an Integrated Pre-Filled Syringe and Autoinjector

WRITTEN BY: Nupur Srivastava

The patients suffering from chronic disease require a regular dose of medicines, either orally or as injections. The patients prefer the self-injection method as it is easy to use, cost-effective, and prevents a monthly visit to the specialists.

Because chronic diseases require repeated dosing of medicines, the market for self-injections grew at over 22% per year towards nearly $80 billion by 2022.

“This move towards injection of biologics at home is a clear trend in our society and our industry, and it presents a clear challenge for device developers,” says John A. Merhige, Chief Commercial Officer, Credence MedSystems, Inc.

Video courtesy: Dove Medical Press 

Becton, Dickinson, and Company (BD) is a global leader in medical technology and self-injection systems. BD announced the launch of Intevia at Parental Drug Association’s (PDA) 2019 Universe of Pre-Filled Syringes and Injection Devices conference held in Gothenburg, Sweden. BD Intevia is a 1mL two-step integrated platform device that combines both an autoinjector and a pre-fillable syringe in one system (Image 1 and a Video). The system favorably optimizes patient self-injections with high-viscous drugs and therapies. 

Peter Nolan, Worldwide President, BD Medical - Pharmaceutical Systems, said: “BD Intevia is a new generation of BD autoinjectors that will help drug manufacturers seamlessly enhance drug delivery experience.” “For the patient, the platform technology is designed to promote patient ease of use when self-injecting, and it is supported by BD’s worldwide clinical injection expertise harnessing the latest research in drug delivery technology,” he added.

Image 1: The features of BD Intevia

The latest validation study participants highly rated BD Intevia autoinjector-prefill syringe and switching to the integrated disposable system for key product attributes as:

  • Overall acceptance, and
  • Confidence to control the start of injection.

Source: MarketSearchEngine, BD Intevia

About the Author
You May Also Like
NOV 11, 2020
Clinical & Molecular DX
Smart Mask Detects COVID Infections, Sends Alert to Phone
NOV 11, 2020
Smart Mask Detects COVID Infections, Sends Alert to Phone
  This week, the Centers for Disease Control and Prevention issued new guidance to put the “mask debate&rdquo ...
NOV 16, 2020
Microbiology
Using the Microbiome to Diagnose or Treat Autism
NOV 16, 2020
Using the Microbiome to Diagnose or Treat Autism
Autism is a complex disorder that has sent researchers searching for what is causing it, as the rates continue to rise. ...
DEC 16, 2020
Clinical & Molecular DX
Gene Marker PACS a Punch for Cervical Cancer Treatments
DEC 16, 2020
Gene Marker PACS a Punch for Cervical Cancer Treatments
In cervical cancer, mutations in healthy cells cause cells to grow and multiply uncontrollably, invading surrounding tis ...
DEC 19, 2020
Clinical & Molecular DX
Urine Tests Sets Parents' Minds at Ease in Minutes After a Miscarriage Threat
DEC 19, 2020
Urine Tests Sets Parents' Minds at Ease in Minutes After a Miscarriage Threat
Researchers have developed a chip-based test that can determine pregnancy outcomes after the signs of a possible miscarr ...
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
JAN 18, 2021
Cancer
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
JAN 18, 2021
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
Breast cancer is one of the most well-studied cancers in modern medicine. Diagnostics can already differentiate between ...
Loading Comments...